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article under the CC BY-NC-ND licenseAbstract When compared with maintenance dialysis, renal transplantation affords patients
with end-stage renal disease better long-term survival and a better quality of life. Approxi-
mately 9% of patients will develop a major urologic complication following kidney transplanta-
tion. Ureteral complications are most common and include obstruction (intrinsic and
extrinsic), urine leak and vesicoureteral reflux. Ureterovesical anastomotic strictures result
from technical error or ureteral ischemia. Balloon dilation or endoureterotomy may be consid-
ered for short, low-grade strictures, but open reconstruction is associated with higher success
rates. Urine leak usually occurs in the early postoperative period. Nearly 60% of patients can be
successfully managed with a pelvic drain and urinary decompression (nephrostomy tube, ure-
teral stent, and indwelling bladder catheter). Proximal, large-volume, or leaks that persist
despite urinary diversion, require open repair. Vesicoureteral reflux is common following trans-
plantation. Patients with recurrent pyelonephritis despite antimicrobial prophylaxis require
surgical treatment. Deflux injection may be considered in recipients with low-grade disease.
Grade IV and V reflux are best managed with open reconstruction.
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Ureteral complications following renal transplantation 2031. Introduction
Annually, more than 40 billion dollars are spent in the
United States treating end-stage renal disease (ESRD) [1].
Over 870,000 individuals suffer from the disease, with
approximately 400,000 patients managed by dialysis and
172,553 people living with functioning renal allografts [1].
Compared to dialysis, renal transplantation affords patients
dramatically improved 5-year survival rates (85.5% vs.
35.8%), while costing the health care system nearly three
times less [1].
Although kidney transplantation is associated with sig-
nificant survival and cost benefits, urologic complications
after surgery do occur. In 2002, Streeter and colleagues [2]
reported an overall major urologic complication rate of
9.2% following 1535 consecutive renal transplants. Ureteral
complications were most common with urine leak and
obstruction occurring in 2.9% and 3.0% of recipients,
respectively. A more recent series of 1670 consecutive
transplants published in 2015 found a urologic complication
rate of 8% [3]. Urine leak occurred in 1.8% of men and 4% of
women, while ureteral stricture formation was observed in
2.4% of male and 1.2% of female recipients. Vesicoureteral
reflux (VUR) following transplantation is common with an
incidence ranging from 50% to 86% [4,5].
Here we review the etiology, clinical presentation,
diagnostic work-up and management of ureteral complica-
tions following renal transplantation. Pertinent studies are
discussed and recommendations are provided to help guide
treatment decisions.2. Evidence acquisition
A literature search was performed using the PubMed data-
base and the terms “transplant”,“ureteral stricture”,
“ureteral obstruction”, “urine leak”, and “vesicoureteral
reflux”. Case reports and non-English manuscripts were
excluded. Full text case series and their references were
reviewed. When feasible, data were combined from mul-
tiple series. However, a formal meta-analysis was not
possible due to the limited and heterogeneous data
available.
3. Evidence synthesis
3.1. Ureteral obstruction
Approximately 1%e4.5% of renal transplant recipients will
develop ureteral obstruction at some time after surgery
[2,3,6]. Distal obstruction is most common. Ureteral
devascularization leading to intrinsic stricture formation is
the principle cause in nearly 90% of cases [7]. Technical
errors during the ureteroneocystostomy, extrinsic
compression (e.g., hematoma, lymphocele, abscess),
kinking of a redundant ureter, collecting system hema-
toma, a stone transplanted with the kidney, and anasto-
motic edema can be causes of obstruction during the early
postoperative (<3 months) period. Late obstruction (>3
months) usually results from ureteral ischemia, but vascu-
litis secondary to acute rejection, lymphocele, fibrosis fromimmunosuppressant medications, and ureterolithiasis may
also occur.
A variety of recipient, donor and operative details have
been evaluated as predictors of ureteral obstruction
following transplantation [8]. Allografts with more than two
renal arteries and from donors older than 65 years of age
are at increased risk [9]. The authors theorized that mul-
tiple renal arteries might correlate with “insufficient infe-
rior pole perfusion, producing relative ischemia to the
ureter”. Prolonged ischemia time and ureter-
oneocystostomy without ureteral stent placement have
also been correlated with stricture formation [8]. Operative
parameters not associated with obstruction include
retrieval modality (open versus laparoscopic), preservation
of the gonadal vessels during donation, and reimplantation
technique (intra- vs. extravesical) [8].
A kidney transplant recipient rarely develops symptoms
of ureteral obstruction unless urinary tract reconstruction
was done by pyeloureterostomy or ureteroureterostomy to
the native ureter because the renal allograft is denervated.
As a result, recipients typically present with an asymp-
tomatic decline in renal function and a decrease in urine
output. Less commonly, patients will complain of a dull
ache or feeling of fullness over the allograft due to irrita-
tion of adjacent peritoneum.
Transplant recipients presenting with an acute decline in
renal function should undergo anatomic imaging (Fig. 1).
Renal ultrasonography (US) is an excellent study to screen
for hydroureteronephrosis. If present, computed tomogra-
phy (CT) should be considered, especially in the early
postoperative period, because of its ability to identify both
intrinsic (e.g., ureteral calculus) and extrinsic (e.g., lym-
phocele, hematoma) sources of obstruction. Collecting
system dilation without a clear etiology should prompt a
nuclear medicine scan with furosemide washout to confirm
the presence of obstruction (Tip: be certain the bladder is
empty during the study). Hydroureteronephrosis without
blockage is concerning for VUR and a voiding cystour-
ethrogram (VCUG) should be done.
Decompression of the collecting system to minimize
allograft injury is the initial priority in recipients with
ureteral obstruction. Both ureteral stent and nephrostomy
tube placement are options. However, ureteral stent
placement is often challenging due to the anterolateral
location of the ureteroneocystostomy, anastomotic edema,
ureteral tortuosity, and distal obstruction. Consequently, it
is the authors’ opinion that percutaneous nephrostomy
tube placement should be considered first-line treatment in
most recipients.
Following decompression, the cause of obstruction must
be fully characterized unless it is obvious (e.g., ureteral
stone). Antegrade pyelography during nephrostomy tube
placement is usually diagnostic (Fig. 2). The location and
severity of urine leaks and ureteral strictures can often be
defined. On occasion combined antegrade and retrograde
contrast studies will be required to accurately determine
stricture length. Pyelography should be delayed in patients
presenting with a febrile urinary tract infection (UTI) until
the infection has resolved.
Obstruction from blood clots within the collecting sys-
tem and edema of the ureteroneocystostomy will resolve
with conservative management. Clot obstruction is usually
Figure 1 Work-up and management of acute renal insufficiency after transplantation.
204 B.D. Duty, J.M. Barryapparent on noncontrast CT as high-density fluid (60e90
Housfield Units) within the collecting system and filling
defects on antegrade pyelography. Nephrostomy tube
drainage is continued until urokinase has lysed the hema-
toma and the patient’s hematuria has resolved. The neph-
rostomy tube is then capped and removed 48 to 72 h later if
the urine output remains appropriate and there is no
decline in renal function. A similar strategy may be
employed for obstruction due to anastomotic edema.
Fluid collections that cause extrinsic ureteral obstruc-
tion should be drained percutaneously. The aspirate is sent
for cell count, gram stain, culture, and creatinine deter-
mination. A fluid creatinine well above the serum level is
consistent with aurinoma. Management of urinary extrav-
asation is detailed below. Small lymphoceles may resolve
following percutaneous drainage but conservative man-
agement fails in over 50% of recipients [10]. Improved
success rates following sclerosis of the lymphocele cavity
with doxycycline, ethanol, povidone-iodine, bleomycin,
talc and fibrin glue have been reported, but periureteral
fibrosis is a potential risk. Persistent or recurrent lympho-
celes are treated with either laparoscopic or open unroof-
ing into the peritoneal cavity. Success rates with both
techniques exceed 88% [11]. However, laparoscopic
drainage is usually not feasible for lymphoceles lateral to
the renal allograft [12].
Depending upon the length of the involved segment,
ureteral strictures have traditionally been managed by
open ureteroneocystostomy or more complex reconstruc-
tive procedures. In select cases, endourologic techniques
have been utilized in an effort to spare patients the po-
tential morbidity of open reconstruction. Treatment op-
tions include ureteral balloon dilation and
endoureterotomy. Endoureterotomy may be performed
with a cold knife, Acucise (Applied Medical Systems, LagunaHill, CA, USA) balloon-cutting catheter or Holmium laser.
Ureteral balloon dilation and Acucise endoureterotomy are
performed under fluoroscopic guidance making them ideal
for both antegrade and retrograde treatment. Cold knife
and laser endoureterotomy require endoscopic visualiza-
tion of the strictured ureteral segment. As a result, treat-
ment of distal strictures frequently requires an antegrade
approach.
Multiple contemporary series have been published eval-
uating the efficacy of primary balloon dilation [13e16].
These studies included a total of 94 patients with a mean
follow-up of 37.3 months (range 17e78 months). Their
overall success rate was 51% (range 44%e62%) following
initial treatment but declined to 25% with repeat dilation.
One series found improved success if treatment was per-
formedwithin 3months of transplantation (74% vs. 44%) [16].
First reported in 1993, the Acucise balloon-cutting de-
vice has been primarily used to treat ureteropelvic junction
obstructions. Several small series have detailed its use for
post-transplant ureteral strictures [17e20]. A total of 21
patients were treated with a mean follow-up of 19 months
(range 13e27 months) and an overall success rate of 78%
(range 60%e100%). Although success rates are better when
compared to primary balloon dilation, the Acucise device is
rarely used because of the bleeding risk associated with
blind ureteral incision [21].
Direct vision endoureterotomy affords patients
improved success rates when compared to balloon dilation,
and decreases the risk of perioperative hemorrhage asso-
ciated with blind ureteral incision. Several series have been
published with a mean success rate and follow-up of 79%
(range 63%e100%) and 29 months, respectively [6,22e25].
It should be highlighted that these series are small and
heterogeneous. They include patients treated by the cold
knife, electrocautery and Holmium laser techniques.
Figure 2 Work-up and management of transplant ureteral
complications.
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Urine leak is the most common early urologic complication
following renal transplantation, with an incidence ranging
from 1.2% to 8.9% [2,3,26]. Devascularization of the distal
ureter during organ harvest is the primary risk factor for
this complication. Poor construction of the ureter-
oneocystostomy may also result in a non-watertight
anastomosis.
Data regarding the effectiveness of routine ureteral
stent placement during transplantation to prevent urine
leak are equivocal. One randomized study involving 194
transplant recipients found a benefit [27]. The incidence of
urine leak in the stented group was only 1% compared to 6%
in the unstented group. A larger randomized study involving
280 recipients found no significant difference between the
two groups (3.5% stented vs. 6.6% unstented; p Z 0.23)
[28].
Patients presenting with a urine leak following trans-
plantation are initially managed with placement of a Foley
catheter and percutaneous nephrostomy tube to divert
urine away from the region of extravasation. Large urino-
mas should be drained percutaneously to minimize the risk
of infection and prevent ureteral obstruction.
An antegrade nephrostogram at the time of nephrostomy
tube placement will determine the extent and location of
the extravasation. If the urine leak is distal and low-
volume, then conservative management can be consid-
ered. This requires maximal decompression with a neph-
rostomy tube, ureteral stent and bladder catheter. Periodic
contrast studies are performed. The patient’s nephrostomytube and bladder catheter are removed once the leak has
resolved. The ureteral stent is removed 4e6 weeks later.
Close monitoring (plasma creatinine and renal US) is
required following stent removal because of the risk of
secondary stricture.
The effectiveness of conservative therapy has been re-
ported in several small series [29e33]. An overall success
rate of 62% (range 36%e87%) was reported at a mean
follow-up of 35 months (range 24e67 months). However,
two patients died from sepsis and three grafts were lost in
one series [29].
Patients with proximal or extensive urine leaks should
not be managed conservatively. Extravasation that does not
resolve following maximal urinary diversion also requires
exploration. Urinomas are drained, devitalized ureter is
resected, and a repeat ureteral reimplantation is per-
formed. If the residual, viable ureter is short, a bladder flap
may be required. Patients with ureterocutaneous or ves-
icocutaneous fistula should undergo resection of the tract
and omental interposition as well.3.3. Vesicoureteral reflux
Vesicoureteral reflux following renal transplantation is
common, and some authors report an incidence as high as
50%e86% [4,5]. Reflux is largely due to surgical technique
and many surgeons favor a patulous ureteroneocystostomy
over a tunneled reimplant in an effort to minimize the risk
of ureteral stricture.
The long-term impact of VUR on renal transplant func-
tion and pyelonephritis is unclear. A study published in 2009
compared 15 recipients with reflux to 22 without [34]. Each
patient had at least one UTI in the previous year and was 2
or more years out from surgery. No difference was found in
the number of infections per year, plasma creatinine levels,
graft and overall patient survival between the two groups.
However, the study did not include any patients with grade
IV or V reflux. Jung and colleagues [35] published a similar
study involving 75 transplant recipients, but 61.3% of the
VUR group had grade IV or V disease. Similarly, no differ-
ence was noted in renal function or the UTI rate between
the two cohorts, but follow-up was less than 1 year. A study
of recipients followed up to 5 years after surgery found a
higher incidence of hypertension and a trend towards an
increased risk of urosepsisin VUR patients [5].
Transplant patients with recurrent UTIs, in particular
pyelonephritis, should be evaluated for vesicoureteral
reflux with a VCUG. Recipients with reflux should also be
worked-up for voiding dysfunction. High storage pressures
from reduced bladder compliance and capacity may require
augmentation cystoplasty and clean intermittent cathe-
terization. Bladder outlet obstruction is a frequent cause of
secondary reflux in men. Transurethral bladder outlet
procedures have been shown to be safe and effective in
transplant recipients, even in the early postoperative
period (Fig. 3) [36].
A trial of prophylactic antibiotics may be considered in
patients with low-grade reflux (grade I-III). Breakthrough
infections or the diagnosis of high-grade VUR should prompt
surgical therapy. A redo ureteroneocystostomy or end-to-
side ureteroureterostomy to the ipsilateral native ureter
Figure 3 Sixty-two years old man with end-stage renal disease from polycystic kidney disease who underwent a living unrelated
renal transplant. Work-up for worsening allograft function included urodynamics and a voiding cystourethrogram (A), which
demonstrating grade IV reflux and primary bladder neck obstruction. Following a transurethral incision of the bladder neck a repeat
voiding cystourethrogram (B) revealed resolution of his reflux. His allograft function has remained stable.
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these reconstructive techniques, they are invasive and may
result in an anastomotic stricture, ureteral necrosis, urine
leak, and persistent reflux.
Stenberg and Lackgren [37] first reported the use of
dextranomer/hyaluronic acid copolymer (Deflux) to endo-
scopically treat VUR in 1995. In contrast to other agents,
Deflux has minimal particle migration and rarely incites an
immunogenic foreign body response. Consequently, it has
been used extensively to treat primary VUR in children.
Success rates of up to 85% have been reported in well-
selected patients [38].
In 2007 the first case series of transplant-associated VUR
treated with Deflux was published [39]. The study included
four women with VUR and worsening graft function. Reflux
resolved following a single injection in one patient and
after two treatments in two recipients. The last woman
required an open ureteral reimplant.
In 2011 Pichler and colleagues [40] published their
experience in a total of 19 recipients who had suffered
three or more UTIs per year. Reflux resolved in 57.9% of
patients after an initial injection, and this increased to
78.9% after two treatments. The authors found a reduction
in the mean number of infections per year from 4.89 to
1.31. Temporary ureteral obstruction that required neph-
rostomy tube placement was encountered in two patients.
The largest study to date included 26 recipients with a
reported overall success rate of 53.8% [41]. Success was
correlated with VUR grade. Ninety percent of patients with
Grade I and II disease were cured following injection
compared to 31% with Grade III and IV reflux.
In summary, vesicoureteral reflux is common after renal
transplantation. Its long-term impact on graft function,
hypertension and recurrent UTIs has not been clearly
delineated. Nonetheless, surgical management should be
strongly considered in patients with worsening renal func-
tion and recurrent pyelonephritis. Deflux is usually suc-
cessful in patients with Grade I and II disease, but patientswith high-grade VUR are best managed with open
reconstruction.
4. Conclusion
Ureteral obstruction, urine leak and vesicoureteral reflux
are the most common urologic complications following
kidney transplantation. Traditionally these complications
have been managed by open reconstruction. Over time,
advances in equipment and endourologic techniques have
allowed many patients to be successfully treated without
the morbidity of open repair. However, endoscopic man-
agement should be approached with caution given the
limited data in the medical literature.Conflicts of interest
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